In a regulatory filing, INmune Bio disclosed that its director Scott Juna bought 5K shares of common stock on June 25th in a total transaction size oF $36.4K. Shares of INmune Bio are up 2% in pre-market at $7.31.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INMB: